Scholars@Duke publication: The effects of clovoxamine on sleep of normal volunteers: A double-blind placebo-controlled study

The effects of clovoxamine on sleep of normal volunteers: A double-blind placebo-controlled study

Publication , Journal Article

Wilson, WH; Ban, T; Coleman, B

Published in: Drug Development Research

1986

In a double-blind placebo-controlled study the effects of clovoxamine on sleep were evaluated. Each of 12 healthy male volunteers was given clovoxamine (50 and 150 mg) and placebo according to a repeated-measures randomized Latin square design. All night sleep EEGs and subjective evaluations of sleep were recorded on each night. Clovoxamine was found to have effects on sleep EEG and subjective evaluation that were consistent with findings reported for other antidepressants such as imipramine.

Duke Scholars

Author William Herman Wilson Psychiatry & Behavioral Sciences, Behavioral Medicine & Neur ...

Published In

Drug Development Research

Publication Date

1986

Volume

Issue

Start / End Page

293 / 298

Related Subject Headings

Pharmacology & Pharmacy
1115 Pharmacology and Pharmaceutical Sciences

Citation

APA

Chicago

ICMJE

MLA

NLM

Wilson, W. H., Ban, T., & Coleman, B. (1986). The effects of clovoxamine on sleep of normal volunteers: A double-blind placebo-controlled study. Drug Development Research, 9(4), 293–298.

Wilson, W. H., T. Ban, and B. Coleman. “The effects of clovoxamine on sleep of normal volunteers: A double-blind placebo-controlled study.” Drug Development Research 9, no. 4 (1986): 293–98.

Wilson WH, Ban T, Coleman B. The effects of clovoxamine on sleep of normal volunteers: A double-blind placebo-controlled study. Drug Development Research. 1986;9(4):293–8.

Wilson, W. H., et al. “The effects of clovoxamine on sleep of normal volunteers: A double-blind placebo-controlled study.” Drug Development Research, vol. 9, no. 4, 1986, pp. 293–98.

Wilson WH, Ban T, Coleman B. The effects of clovoxamine on sleep of normal volunteers: A double-blind placebo-controlled study. Drug Development Research. 1986;9(4):293–298.